Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVOLVE: A Prospective Randomized Multicenter Single-blind Non-inferiority Trial to Assess the Safety and Performance of the Evolution Everolimus-Eluting Monorail Coronary Stent System (Evolution Stent System) for the Treatment of a De Novo Atherosclerotic Lesion

NCT01135225 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01135225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01135225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVOLVE: A Prospective Randomized Multicenter Single-blind Non-inferiority Trial to Assess the Safety and Performance of the Evolution Everolimus-Eluting Monorail Coronary Stent System (Evolution Stent System) for the Treatment of a De Novo Atherosclerotic Lesion
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2010
Completion date
April 30, 2016
Enrollment
291 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease